Atezolizumab Plus Bevacizumab in Advanced HCC: Efficacy in NASH-Specific Etiology

Josep M. Llovet, Mathias Heikenwalder

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)1308-1310
Number of pages3
JournalGastroenterology
Volume165
Issue number5
DOIs
StatePublished - Nov 2023

Cite this